Concepts (162)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| HIV Long Terminal Repeat | 1 | 2018 | 16 | 0.76 | Why? |
| Gene Products, gag | 1 | 2018 | 28 | 0.76 | Why? |
| Genes, pol | 1 | 2018 | 38 | 0.76 | Why? |
| RNA, Guide | 2 | 2018 | 269 | 0.69 | Why? |
| Herpes Genitalis | 3 | 2018 | 90 | 0.50 | Why? |
| Herpesvirus 2, Human | 3 | 2018 | 137 | 0.49 | Why? |
| CRISPR-Cas Systems | 2 | 2018 | 1397 | 0.47 | Why? |
| Herpesvirus 6, Human | 2 | 2018 | 162 | 0.31 | Why? |
| Washington | 5 | 2021 | 1722 | 0.29 | Why? |
| Gene Editing | 2 | 2018 | 330 | 0.28 | Why? |
| Genome, Viral | 9 | 2021 | 13157 | 0.26 | Why? |
| Real-Time Polymerase Chain Reaction | 3 | 2021 | 11367 | 0.25 | Why? |
| HIV-1 | 1 | 2018 | 3365 | 0.25 | Why? |
| Nuclear Matrix-Associated Proteins | 1 | 2021 | 50 | 0.22 | Why? |
| Phylogeny | 10 | 2021 | 13341 | 0.22 | Why? |
| Nucleocytoplasmic Transport Proteins | 1 | 2021 | 73 | 0.22 | Why? |
| Nuclear Pore Complex Proteins | 1 | 2021 | 53 | 0.22 | Why? |
| Gene Fusion | 1 | 2020 | 25 | 0.21 | Why? |
| Roseolovirus Infections | 2 | 2018 | 131 | 0.20 | Why? |
| Genetic Therapy | 3 | 2018 | 409 | 0.19 | Why? |
| Replication Origin | 1 | 2018 | 16 | 0.19 | Why? |
| Tandem Repeat Sequences | 1 | 2018 | 78 | 0.19 | Why? |
| Cell Nucleus | 1 | 2021 | 399 | 0.18 | Why? |
| Genomic Instability | 1 | 2018 | 80 | 0.18 | Why? |
| DNA Copy Number Variations | 1 | 2018 | 84 | 0.18 | Why? |
| Deoxyribonucleases | 1 | 2017 | 34 | 0.18 | Why? |
| Trigeminal Ganglion | 1 | 2017 | 14 | 0.18 | Why? |
| Metabolic Engineering | 1 | 2017 | 41 | 0.18 | Why? |
| Sensory Receptor Cells | 1 | 2017 | 44 | 0.17 | Why? |
| Endonucleases | 1 | 2017 | 68 | 0.17 | Why? |
| Viral Proteins | 3 | 2021 | 7370 | 0.16 | Why? |
| Virus Latency | 1 | 2018 | 251 | 0.16 | Why? |
| Transgenes | 1 | 2017 | 227 | 0.16 | Why? |
| Dependovirus | 1 | 2017 | 272 | 0.15 | Why? |
| Sequence Deletion | 1 | 2020 | 674 | 0.15 | Why? |
| Superinfection | 1 | 2020 | 459 | 0.15 | Why? |
| Genetic Variation | 3 | 2018 | 3919 | 0.14 | Why? |
| Alleles | 1 | 2021 | 1557 | 0.14 | Why? |
| Herpesvirus 1, Human | 1 | 2018 | 286 | 0.14 | Why? |
| Conserved Sequence | 1 | 2017 | 751 | 0.14 | Why? |
| Herpes Simplex | 1 | 2018 | 272 | 0.14 | Why? |
| Virus Cultivation | 1 | 2018 | 579 | 0.14 | Why? |
| Metagenomics | 1 | 2020 | 823 | 0.13 | Why? |
| High-Throughput Nucleotide Sequencing | 3 | 2021 | 3633 | 0.13 | Why? |
| Models, Immunological | 1 | 2018 | 727 | 0.12 | Why? |
| Whole Genome Sequencing | 2 | 2020 | 3239 | 0.12 | Why? |
| Genotype | 2 | 2021 | 4697 | 0.11 | Why? |
| Genes, Viral | 1 | 2017 | 1428 | 0.11 | Why? |
| DNA | 1 | 2017 | 778 | 0.11 | Why? |
| Likelihood Functions | 2 | 2020 | 719 | 0.09 | Why? |
| Mutation | 3 | 2021 | 12376 | 0.08 | Why? |
| Gene Expression Profiling | 1 | 2018 | 3788 | 0.08 | Why? |
| Immunologic Memory | 1 | 2018 | 3362 | 0.08 | Why? |
| Genomics | 1 | 2018 | 3118 | 0.08 | Why? |
| Virus Shedding | 2 | 2018 | 5834 | 0.07 | Why? |
| Travel | 2 | 2020 | 7220 | 0.07 | Why? |
| Viruses | 1 | 2018 | 2238 | 0.07 | Why? |
| Betacoronavirus | 7 | 2020 | 204454 | 0.07 | Why? |
| Ships | 2 | 2020 | 1046 | 0.06 | Why? |
| HIV Infections | 2 | 2018 | 11620 | 0.06 | Why? |
| Sequence Analysis, RNA | 2 | 2021 | 2290 | 0.06 | Why? |
| CD8-Positive T-Lymphocytes | 1 | 2018 | 5837 | 0.05 | Why? |
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2021 | 13720 | 0.05 | Why? |
| Active Transport, Cell Nucleus | 1 | 2021 | 203 | 0.05 | Why? |
| Fisheries | 1 | 2020 | 57 | 0.05 | Why? |
| Ribosomal Proteins | 1 | 2020 | 94 | 0.05 | Why? |
| Spike Glycoprotein, Coronavirus | 2 | 2021 | 37182 | 0.05 | Why? |
| Virus Diseases | 1 | 2018 | 3779 | 0.05 | Why? |
| Sequence Analysis, DNA | 2 | 2020 | 2830 | 0.05 | Why? |
| Gene Library | 1 | 2020 | 234 | 0.05 | Why? |
| Humans | 23 | 2022 | 930598 | 0.05 | Why? |
| Pneumonia, Viral | 7 | 2020 | 243684 | 0.05 | Why? |
| Diagnostic Techniques and Procedures | 1 | 2022 | 265 | 0.05 | Why? |
| Coronavirus Infections | 7 | 2020 | 253789 | 0.05 | Why? |
| Los Angeles | 1 | 2022 | 647 | 0.05 | Why? |
| DNA Cleavage | 1 | 2017 | 11 | 0.04 | Why? |
| Connecticut | 1 | 2020 | 547 | 0.04 | Why? |
| Nucleic Acid Hybridization | 1 | 2018 | 140 | 0.04 | Why? |
| Gene Expression Regulation | 2 | 2021 | 4020 | 0.04 | Why? |
| Time Factors | 1 | 2021 | 31397 | 0.04 | Why? |
| Injections, Intradermal | 1 | 2017 | 102 | 0.04 | Why? |
| DNA, Viral | 2 | 2018 | 2521 | 0.04 | Why? |
| Quasispecies | 1 | 2018 | 108 | 0.04 | Why? |
| Epidemiological Monitoring | 2 | 2020 | 3493 | 0.04 | Why? |
| Nasopharynx | 3 | 2020 | 10224 | 0.04 | Why? |
| Genitalia | 1 | 2017 | 98 | 0.04 | Why? |
| Binding Sites | 2 | 2021 | 6201 | 0.04 | Why? |
| Enterovirus | 1 | 2020 | 402 | 0.04 | Why? |
| Transduction, Genetic | 1 | 2017 | 273 | 0.04 | Why? |
| Nucleocapsid | 1 | 2021 | 734 | 0.04 | Why? |
| Wound Healing | 1 | 2020 | 424 | 0.04 | Why? |
| Cells, Cultured | 2 | 2018 | 5835 | 0.04 | Why? |
| Sequence Homology | 1 | 2017 | 448 | 0.04 | Why? |
| South America | 1 | 2017 | 565 | 0.04 | Why? |
| Disease Outbreaks | 2 | 2021 | 27595 | 0.04 | Why? |
| Substrate Specificity | 1 | 2017 | 639 | 0.04 | Why? |
| Serogroup | 1 | 2017 | 510 | 0.03 | Why? |
| Fibroblasts | 1 | 2018 | 839 | 0.03 | Why? |
| Models, Animal | 1 | 2017 | 788 | 0.03 | Why? |
| Cell Line | 2 | 2021 | 12040 | 0.03 | Why? |
| Sequence Alignment | 1 | 2020 | 2109 | 0.03 | Why? |
| Antibodies, Neutralizing | 1 | 2020 | 25288 | 0.03 | Why? |
| Peru | 1 | 2017 | 1010 | 0.03 | Why? |
| California | 1 | 2020 | 2047 | 0.03 | Why? |
| Africa South of the Sahara | 1 | 2017 | 1335 | 0.03 | Why? |
| Kinetics | 1 | 2020 | 3238 | 0.03 | Why? |
| Drug Resistance, Viral | 1 | 2018 | 1083 | 0.03 | Why? |
| Bayes Theorem | 1 | 2020 | 3237 | 0.03 | Why? |
| Sensitivity and Specificity | 2 | 2021 | 22971 | 0.03 | Why? |
| Phosphoproteins | 1 | 2020 | 4346 | 0.03 | Why? |
| Genetic Vectors | 1 | 2017 | 1600 | 0.02 | Why? |
| Base Sequence | 1 | 2018 | 3581 | 0.02 | Why? |
| Age Factors | 2 | 2021 | 21039 | 0.02 | Why? |
| Cluster Analysis | 1 | 2017 | 3001 | 0.02 | Why? |
| Immunity | 1 | 2020 | 2651 | 0.02 | Why? |
| Combined Modality Therapy | 1 | 2018 | 3395 | 0.02 | Why? |
| Flow Cytometry | 1 | 2017 | 2393 | 0.02 | Why? |
| Nucleocapsid Proteins | 1 | 2020 | 3120 | 0.02 | Why? |
| Africa | 1 | 2017 | 2986 | 0.02 | Why? |
| Mice | 2 | 2018 | 21357 | 0.02 | Why? |
| RNA, Viral | 3 | 2020 | 32276 | 0.02 | Why? |
| Antiviral Agents | 1 | 2020 | 41703 | 0.02 | Why? |
| United States | 3 | 2020 | 46150 | 0.02 | Why? |
| Proteomics | 1 | 2018 | 2481 | 0.02 | Why? |
| RNA, Messenger | 1 | 2021 | 5131 | 0.02 | Why? |
| Carrier State | 1 | 2018 | 2100 | 0.02 | Why? |
| Adolescent | 3 | 2021 | 86841 | 0.02 | Why? |
| Child, Preschool | 2 | 2020 | 36283 | 0.02 | Why? |
| Young Adult | 3 | 2021 | 93724 | 0.02 | Why? |
| Evolution, Molecular | 1 | 2018 | 3691 | 0.02 | Why? |
| Polymorphism, Single Nucleotide | 1 | 2017 | 3607 | 0.02 | Why? |
| Machine Learning | 1 | 2021 | 4395 | 0.02 | Why? |
| Protein Binding | 1 | 2021 | 11430 | 0.02 | Why? |
| Animals | 3 | 2018 | 78931 | 0.02 | Why? |
| Chronic Disease | 1 | 2018 | 5139 | 0.02 | Why? |
| Signal Transduction | 1 | 2020 | 7207 | 0.02 | Why? |
| HEK293 Cells | 1 | 2017 | 8394 | 0.02 | Why? |
| Sex Factors | 1 | 2020 | 11014 | 0.02 | Why? |
| Computer Simulation | 1 | 2017 | 4982 | 0.02 | Why? |
| Male | 5 | 2021 | 367725 | 0.01 | Why? |
| Female | 5 | 2021 | 380317 | 0.01 | Why? |
| Adult | 4 | 2021 | 244371 | 0.01 | Why? |
| Pandemics | 7 | 2020 | 389249 | 0.01 | Why? |
| Vero Cells | 1 | 2017 | 14117 | 0.01 | Why? |
| Aged, 80 and over | 2 | 2021 | 88759 | 0.01 | Why? |
| Child | 2 | 2020 | 70012 | 0.01 | Why? |
| Viral Load | 1 | 2020 | 15850 | 0.01 | Why? |
| Aged | 3 | 2021 | 215776 | 0.01 | Why? |
| Incidence | 1 | 2020 | 25622 | 0.01 | Why? |
| Antibodies, Viral | 2 | 2021 | 51949 | 0.01 | Why? |
| Prognosis | 1 | 2021 | 32490 | 0.01 | Why? |
| Middle Aged | 3 | 2021 | 270681 | 0.01 | Why? |
| Virus Replication | 1 | 2018 | 14331 | 0.01 | Why? |
| Infant, Newborn | 1 | 2018 | 23105 | 0.01 | Why? |
| Immunoglobulin G | 1 | 2020 | 21571 | 0.01 | Why? |
| Infant | 1 | 2018 | 30274 | 0.01 | Why? |
| Global Health | 1 | 2018 | 13911 | 0.01 | Why? |
| Cohort Studies | 1 | 2018 | 36005 | 0.01 | Why? |
| Cross-Sectional Studies | 1 | 2017 | 53120 | 0.01 | Why? |
| Retrospective Studies | 1 | 2022 | 105322 | 0.01 | Why? |
| Hospitalization | 1 | 2021 | 54280 | 0.01 | Why? |
| Risk Factors | 1 | 2017 | 71621 | 0.01 | Why? |
Roychoudhury's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts
(162)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(220)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_